Blade Therapeutics Announces Appointment of Jean-Frédéric Viret as Chief Financial OfficerBusiness Wire • 03/22/21
Coherus BioSciences, Inc. (CHRS) CEO Denny Lanfear on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/25/21
Coherus BioSciences (CHRS) Misses Q4 Earnings and Revenue EstimatesZacks Investment Research • 02/24/21
Coherus BioSciences Reports Fourth Quarter and Full Year 2020 Financial ResultsGlobeNewsWire • 02/24/21
Earnings Preview: Coherus BioSciences (CHRS) Q4 Earnings Expected to DeclineZacks Investment Research • 02/18/21
Coherus BLA Filing for Adalimumab Biosimilar Candidate Accepted by FDA for ReviewGlobeNewsWire • 02/17/21
Week In Review: Junshi Signs $1.1 Billion Deal For U.S.-Canada Rights To PD-1Seeking Alpha • 02/07/21
Coherus BioSciences Appoints Alan Mendelson and Mark Stolper to Board of DirectorsGlobeNewsWire • 01/07/21
Coherus BioSciences Management to Present at the 39th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/05/21
Coherus BioSciences, Inc. (CHRS) CEO Denny Lanfear on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/08/20
Coherus BioSciences (CHRS) Lags Q3 Earnings and Revenue EstimatesZacks Investment Research • 11/05/20
Coherus BioSciences (CHRS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZacks Investment Research • 10/29/20
Why Coherus BioSciences (CHRS) is Poised to Beat Earnings Estimates AgainZacks Investment Research • 10/26/20
Coherus BioSciences (CHRS) Moves to Buy: Rationale Behind the UpgradeZacks Investment Research • 10/26/20
Coherus BioSciences to Report Third Quarter Financial Results on November 5thGlobeNewsWire • 10/22/20
Coherus BioSciences' (CHRS) CEO Denny Lanfear on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/08/20
Coherus BioSciences (CHRS) Q2 Earnings and Revenues Top EstimatesZacks Investment Research • 08/07/20
Earnings Preview: Coherus BioSciences (CHRS) Q2 Earnings Expected to DeclineZacks Investment Research • 07/30/20